Skip to main content
Clinical Trials/NCT02206399
NCT02206399
Completed
Not Applicable

Non-Invasive Hemoglobin Multi-Center Observational Study

Convergence Biometrics1 site in 1 country237 target enrollmentAugust 2014
ConditionsAnemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anemia
Sponsor
Convergence Biometrics
Enrollment
237
Locations
1
Primary Endpoint
Percentage of Hemoglobin in Blood At Time of Test
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The investigators clinical trials will be for a medical device that is non-invasive in nature. The investigators will be studying whether their non-invasive medical device gets data that is as good as, or better than, an FDA previously approved, blood analysis device. There is no study hypothesis for this study.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
November 2014
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Convergence Biometrics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percentage of Hemoglobin in Blood At Time of Test

Time Frame: Up to 30 seconds

Study Sites (1)

Loading locations...

Similar Trials